Breakthrough sepsis drug shows promise in human trial

1 week ago 16
ARTICLE AD BOX

Researchers at Griffith University report encouraging progress toward treating sepsis after a Phase II clinical trial in China produced positive results. The study suggests a new drug candidate may reduce the severity of sepsis, a condition that affects millions of hospitalized patients worldwide each year.

The experimental treatment, known as STC3141, is a carbohydrate-based drug developed through a collaboration between Distinguished Professor Mark von Itzst...

Read Entire Article